IP Verse

Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases

Patent No. EP2506857 (titled "Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases") was filed by Shire Human Genetic Therapies on Nov 30, 2010. The application was issued on Feb 14, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRADYNov 14, 2018EIP
WITHERS & ROGERSNov 14, 2018GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2506857

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP10835016A
Filing Date
Nov 30, 2010
Status
Revoked
May 4, 2024
Publication Date
Feb 14, 2018
External Links
Slate, Register , Google Patents